CONFLICT OF INTEREST STATEMENT None declared. Supporting Information Filename Description jdv20534-sup-0001-Supinfo.docxWord 2007 document , 18.2 KB Data S1. REFERENCES 1, . Janus kinase inhibitors for the treatment of atopic dermatitis: focus on Abrocitinib, Baricitinib, and Upadacitinib. Dermatol Pract Concept. 2021; 11(4):e2021145. https://doi.org/10.5826/dpc.1104a145 2, , , , , . Biologics for treatment of atopic dermatitis: current status and future Prospect. J Allergy Clin Immunol Pract.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with M. E.
Contact M. E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack